Lee Tom Y's Form 4 filing
Pure Bioscience, Inc. (PURE) · filed Mar 22, 2022
- Accession no.
- 0001209191-22-020677
- Filed
- Mar 22, 2022, 9:49 PM ET
- Trade date
- Mar 16-21, 2022
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $42.8K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee Tom YCIK 0001623609 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | Common Stock | PPurchaseAcquired | +21,227 | $0.18 | +$3,820.86 | 4,753,593 | Direct | |
| Mar 17, 2022 | Common Stock | PPurchaseAcquired | +13,250 | $0.179 | +$2,371.75 | 4,766,843 | Direct | |
| Mar 21, 2022 | Common Stock | PPurchaseAcquired | +185,000 | $0.198 | +$36,630 | 4,951,843 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.